Autopsy report · NCT04293692
Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus
Cause of deathStaffing, sites or logistics
“Patients were transferred to designated hospitals for treatment as needed, the clinical trials cannot be conducted.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- Puren Hospital Affiliated to Wuhan University of Science and Technology
- Sponsor type
- University, hospital or other
- Conditions
- COVID-19
- Interventions
- UC-MSCs; Placebo
- Participants
- 0
- Sites
- 1
- Countries
- China
Trials that died the same way
- Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More
“Feasibility of the clinical trial could not be confirmed at the different sites.” - Evaluation of the Efficacy of Bio-K+ Cl-1285® In the Nasal Decolonization of Methicillin Resistant Staphylococcus Aureus (MRSA) Carrier Patients
“Unable to recruit patients to continue on with the study.” - A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
“Unable to recruit patients.” - A Randomized, Prospective Clinical Trial of Immediate Flap Closure Versus Wound Care for Management of Late-stage Pressure Ulcers
“We have not been able to enroll patients.” - Comparison of Three Approaches of Electrode Placement to Detect Changes in Motor Evoked Potentials During Spine Surgery
“Unable to enroll patients.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.